drugset / Trial / NCT02421263

The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals

NCT02421263

Phase 1 Completed 12 enrolled NYU Langone Health
RandomizedParallel-groupOpen-labelHealth-services research

Summary

The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders. We hypothesize that religious professionals, given their interests, training, and life experience, will be able to make nuanced discriminations of their psilocybin experiences, thus contributing to the scientific understanding of mystical-type experience. As we better characterize the phenomenology of psilocybin-induced mystical experiences, we may apply this knowledge to improve potential treatment studies in the future. A primary objective is to investigate changes in psychological functioning, spirituality, health, well-being, prosocial attitudes and behavior in professional religious leaders that may occur after receiving psilocybin under supportive conditions. A secondary objective is to determine whether participants who report having had the strongest mystical-type effects during psilocybin sessions will show the largest positive changes in the Interim Questionnaire.

Timeline

Start
2015-04
Primary completion
2020-06-05
Completion
2020-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 0.285714 mg/kg
Subject Psilocybin Other / unclassified 0.428571 mg/kg

Indications

No indication recorded.